بثژ تنها واکسن موجود جهت مقابله با بیماری سل: مقاله مروری
Authors
Abstract:
Background: Despite advances in the vaccinology and chemotherapy in the past century, tuberculosis is still responsible for two million deaths every year. Emergence of multi-drug resistant strain and coinfection of TB-HIV make it a serious concern. Treatment and control of tuberculosis is a great health burden in every community. Active tuberculosis in children has very severe consequences especially those who are under 5-years-old, therefore vaccine indication should be taken. Bacille Calmette-Guérin (BCG) is a live attenuated strain of Mycobacterium bovis that has been used for providing immunity or protection against tuberculosis (TB). In addition, BCG provides relative protection against leprosy and Buruli ulcer, it also can be used for treatment of bladder cancer. BCG is the most widely administered vaccine around the world. It has been given to over three billion individuals over the past decades. At first it was developed in 1908 at the Pasteur Institute in Lille by Albert Calmette and Camille Guérin. In fact BCG is a strain of Mycobacterium bovis that bear deletion in its genome following too long subculture in special media. Deletion in region of deletion 1 (RD1), a specific region of Mycobacterium bovis genome, has decreased pathogenicity of BCG strain. Following culture of BCG on different media since 1921 make genetic variation in the BCG strains that have specific characteristics. BCG should begin given to only immune-competent individuals and should not be administered to immunocompromised people. This vaccine is not effective in people formerly infected or sensitized with environmental mycobacteria. Previous meta-analysis studies indicate that BCG has variable range of protection from 0 to 80 percent against pulmonary TB, but is very effective against severe disseminated forms such as meningitis and miliary form of TB. Despite many research and develop new generation vaccine against TB, BCG vaccine still remains as the only effective vaccine because many efforts to replace it with better ones were unsuccessful.
similar resources
ب ث ژ تنها واکسن موجود جهت مقابله با بیماری سل: مقاله مروری
با وجود پیشرفت های بسیار در حوزه دارو و واکسن در طی یک قرن گذشته بیماری توبرکلوزیس هنوز مسئول بیش از دو میلیون مرگ در هر سال می باشد. پیدایش سویه های مقاوم به دارو و عفونت همزمان توبرکلوزیس و ایدز آن را به یک مشکل جدی بدل کرده است و درمان و کنترل آن بار بزرگی بر دوش جامعه ایجاد نموده است. عفونت توبرکلوزیس در کودکان با عوارض شدیدی همراه است به ویژه در آن هایی که کمتر از پنج سال سن دارند، بنابرای...
full textتظاهرات جراحی بیماری پاژه استخوان (مقاله مروری)
Paget’s disease is a chronic non-metabolic bone disorder that is characterized by increased bone resorption, bone formation and remodeling. This unbalanced process may lead to osseous deformities, structural weakness and altered joint biomechanics all of which can make surgical reconstruction difficult. Although few patients with Paget’s disease ever require surgical treatment, successful surgi...
full textپره اکلامپسی و بیماری پریودنتال: مقاله مروری
Periodontal disease is one of the most common chronic infectious diseases in humans. In recent years, an association was found between periodontitis and some systemic diseases such as cardiovascular disorders, problems during pregnancy, diabetes, cerebrovascular diseases, and respiratory disorders. Complications that may arise during pregnancy include pretem birth, low birth weight, intrauterin...
full textعفونت سل نهفته در کارکنان مراکز درمانی: مقاله مروری
The members of Mycobacterium tuberculosis complex (MTBC) known as causative agents of human tuberculosis. Tuberculosis infection is one of the most important occupational risks for healthcare workers (HCWs) in most countries, such as Iran. In general, there are two types of tuberculosis, they include: latent infection and active TB. Latent tuberculosis infection (LTBI) means: a patient is infec...
full textروش های تشخیص سل فعال ریوی (مقاله مروری)
لطفا برای مشاهده چکیده به متن کامل (pdf) مراجعه فرمایید.
full textلپتوسپیروزیا بیماری ویل (یک بیماری تب دار همراه با زردی) (مقاله مروری)
لپتوسپیروزیک بیماری باکتریائی مشترک بین انسان و دام است که توسط اسپیروکت هایی از جنس لپتوسپیرا ایجاد می شود و انسان و تعداد زیادی از جانوران را مبتلا می سازد. این بیماری نخستین بار توسط آدولف ویل در سال 1886 توصیف شد که آن را یک بیماری حاد تب دار با تب و زردی گزارش نمود. اپیدمی های محدود لپتوسپیروز معمولا در اثر مواجهه انسان با خاک یا آب آلوده به ادرار حیوانات دچار عفونت از طریق پوست آسیب دیده ...
full textMy Resources
Journal title
volume 74 issue None
pages 675- 681
publication date 2017-01
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023